Literature DB >> 172009

Efficacy of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate in therapy of equine abortion virus-induced hepatitis in hamsters.

L B Allen, J H Huffman, G R Revankar, R L Tolman, L N Simon, R K Robins, R W Sidwell.   

Abstract

Equine abortion virus (EAV)-induced hepatitis in hamsters presents an interesting animal model for the evaluation of drugs possessing anti-deoxyribonucleic acid virus activity. These experiments demonstrate that 9-beta-d-arabinofuranosylhypoxanthine 5'-monophosphate (ara-HxMP), a new synthetic, water-soluble, antiviral agent, effectively controls this disease in hamsters with a therapeutic index of approximately 60. Ara-HxMP prevented hepatitis-associated deaths in hamsters, reduced the titer of EAV developing in hamsters, and inhibited the increase of serum glutamic pyruvic transaminase in EAV-infected hamsters.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 172009      PMCID: PMC429375          DOI: 10.1128/AAC.8.4.474

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  6 in total

1.  Propagation of equine abortion virus in Syrian hamsters.

Authors:  E R DOLL; J T BRYANS; W H MCCOLLUM; E W CROWE
Journal:  Cornell Vet       Date:  1956-01

2.  Studies on hepatitis in hamsters infected with equine abortion virus. I. Sequential development of inclusions and the growth cycle.

Authors:  C C RANDALL; E C BRACKEN
Journal:  Am J Pathol       Date:  1957 Jul-Aug       Impact factor: 4.307

3.  Effect of antiviral agents in equine abortion virus-infected hamsters.

Authors:  M Lieberman; A Pascale; T W Schafer; P E Came
Journal:  Antimicrob Agents Chemother       Date:  1972-02       Impact factor: 5.191

4.  DNA of a human hepatitis B virus candidate.

Authors:  W S Robinson; D A Clayton; R L Greenman
Journal:  J Virol       Date:  1974-08       Impact factor: 5.103

5.  Recent developments in viral hepatitis therapy.

Authors:  D Hollander
Journal:  Geriatrics       Date:  1973-04

6.  Synthesis and antiviral activity of certain 5'-monophosphates of 9-D-arabinofuranosyladenine and 9-D-arabinofuranosylhypoxanthine.

Authors:  G R Revankar; J H Huffman; L B Allen; R W Sidwell; R K Robins; R L Tolman
Journal:  J Med Chem       Date:  1975-07       Impact factor: 7.446

  6 in total
  6 in total

1.  Viral keratitis-inhibitory effect of 9-beta-D-arabinofuranosylhypoxanthine 5'-monophosphate.

Authors:  R W Sidwell; L B Allen; J H Huffman; G R Revankar; R K Robins; R L Tolman
Journal:  Antimicrob Agents Chemother       Date:  1975-10       Impact factor: 5.191

2.  Effective chemotherapy of equine herpesvirus 1 by phosphonylmethoxyalkyl derivatives of adenine demonstrated in a novel murine model for the disease.

Authors:  H J Field; A R Awan
Journal:  Antimicrob Agents Chemother       Date:  1990-05       Impact factor: 5.191

3.  Effects of phosphonylmethoxyalkyl derivatives studied with a murine model for abortion induced by equine herpesvirus 1.

Authors:  A R Awan; H J Field
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

4.  Relative activities of acyclovir and BW759 against Aujeszky's disease and equine rhinopneumonitis viruses.

Authors:  E A Rollinson; G White
Journal:  Antimicrob Agents Chemother       Date:  1983-08       Impact factor: 5.191

5.  Susceptibility of bovid herpesvirus 1 to antiviral drugs: in vitro versus in vivo efficacy of (E)-5-(2-Bromovinyl)-2'-deoxyuridine.

Authors:  L A Babiuk; S D Acres; V Misra; P H Stockdale; E De Clercq
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

6.  Effect of ribavirin on viral hepatitis in laboratory animals.

Authors:  R W Sidwell; J H Huffman; N Campbell; L B Allen
Journal:  Ann N Y Acad Sci       Date:  1977-03-04       Impact factor: 5.691

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.